(Q48263882)

English

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.

scientific article published in February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

radiation therapy

0 references

1 reference

based on heuristic

inferred from title

author name string

Cox JD

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Scott CB

2

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Byhardt RW

3

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Emami B

4

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Russell AH

5

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Fu KK

6

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Parliament MB

7

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Komaki R

8

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Gaspar LE

9

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

43

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

505-509

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

3

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II Trial of Combination Chemotherapy and Irradiation in Non-Small-Cell Lung Cancer, Radiation Therapy Oncology Group 88–04

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900429-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(98)00429-5

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/10078629

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48263882&oldid=1406440388"